Aurinia Pharmaceuticals Inc. 8-K

Accession 0001140361-26-020402

Filing information

CIK: 0001600620
Report date: 2026-05-08
Filing date: 2026-05-11
Form: 8-K
Primary document: ef20072568_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.